AXDX Insider Trading
Insider Ownership Percentage: 43.60%
Insider Buying (Last 12 Months): $314,000.00
Insider Selling (Last 12 Months): $83,157.63
Accelerate Diagnostics Insider Trading History Chart
This chart shows the insider buying and selling history at Accelerate Diagnostics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Accelerate Diagnostics Share Price & Price History
Current Price: $0.70
Price Change: ▲ Price Increase of +0.001 (0.14%)
As of 03/31/2025 05:00 PM ET
Accelerate Diagnostics Insider Trading History
SEC Filings (Institutional Ownership Changes) for Accelerate Diagnostics (NASDAQ:AXDX)
17.14% of Accelerate Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at AXDX by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
Accelerate Diagnostics Institutional Trading History
Data available starting January 2016
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Read More on Accelerate Diagnostics
Volume
51,959 shs
Average Volume
60,190 shs
Market Capitalization
$17.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.55
Who are the company insiders with the largest holdings of Accelerate Diagnostics?
Who are the major institutional investors of Accelerate Diagnostics?
Which institutional investors are selling Accelerate Diagnostics stock?
During the previous quarter, AXDX stock was sold by these institutional investors:
- Griffin Asset Management Inc.
- Wolverine Asset Management LLC
During the last year, company insiders that have sold Accelerate Diagnostics company stock include:
- John Patience (Director)
- Jack Phillips (CEO)
- Larry Michael Mertz (CTO)
Learn More investors selling Accelerate Diagnostics stock.
Which institutional investors are buying Accelerate Diagnostics stock?
Within the previous quarter, AXDX stock was purchased by institutional investors including:
- Renaissance Technologies LLC
- Jane Street Group LLC
- Geode Capital Management LLC